Funder
tasly biopharmaceuticals co., ltd
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Neurology (clinical),General Neuroscience
Reference18 articles.
1. Wang X, You S, Sato S, Yang J, Carcel C, Zheng D, Yoshimura S, Anderson CS, Sandset EC, Robinson T, et al. Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: An updated systematic review. Stroke Vasc Neurol. 2018;3:28–33. https://doi.org/10.1136/svn-2017-000112.
2. Hao CH, Ding WX, Sun Q, Li XX, Wang WT, Zhao ZY, Tang LD. Effect of human recombinant prourokinase(rhpro-uk) on thromboembolic stroke in rats. Eur J Pharmacol. 2018;818:429–34. https://doi.org/10.1016/j.ejphar.2017.11.026.
3. Hao C, Ding W, Xu X, Sun Q, Li X, Wang W, Zhao Z, Tang L. Effect of recombinant human prourokinase on thrombolysis in a rabbit model of thromboembolic stroke. Biomed Rep. 2018;8:77–84. https://doi.org/10.3892/br.2017.1013.
4. Takano K, Carano RA, Tatlisumak T, Meiler M, Sotak CH, Kleinert HD, Fisher M. Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging. Neurology. 1998;50:870–5. https://doi.org/10.1212/wnl.50.4.870.
5. Prourokinase Clinical Trial Group. Multicenter phase III study of recombinant prourokinase for acute myocardial infarction with ST-segment evaluation. J Med Res. 2013;42:26–31 ((In Chinese)).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献